Canada markets open in 1 hour 29 minutes

Valneva SE (VLA.VI)

Vienna - Vienna Delayed Price. Currency in EUR
Add to watchlist
11.19+1.09 (+10.85%)
As of 01:39PM CEST. Market open.
Sign in to post a message.
  • s
    selmerstyle
    let’s talk lyme vaccine—when i fist started following this company covid wasn’t even a thing.

    how do we feel about the potential sales for that one…and anything else interesting in the pipeline (tired of the covid vaccine drama…need a new topic of conversation!)
  • J
    John
    losing the EU deal us very bad news.
  • M
    Marcelino
    Zacks Rank & Stock to Consider

    Valnevacurrently carries a Zacks Rank #4 (Sell).
    Zacks Equity Research
    Tue, May 17, 2022, 2:10 PM
  • B
    Blockbuster
    (ADXN) MC $26 mil ..3x Blockbuster including Phase 3 program targeting Parkinsons disease with first big data readout expected during this quarter =Unknown gem with10 Bagger opp
    https://www.addextherapeutics.com/files/cache/cf326ccf928550628a0ca1e43cf43d02_f342.png

    ###
  • J
    John
    You should be happy the stock is only down 20% premarket. That is a gift. Should be down 45 or 50%
  • M
    Marcelino
    I was not acting dishonestly.
    I said strong sell at 16 euros.
    Not at 10 euros like Zack.
    He gave it a better rating before that.
    Only a deal that is now uncertain can't change a company's valuation that much.
  • g
    geragonew
    Guys Check it out oil PED. Earnings is after hour will be exploded.
  • M
    Marcelino
    Money becomes more expensive.
    No profits, only share sales.
    No dividend.
    What is the point of buying this stock?
  • M
    Marcelino
    I told you not to buy
  • M
    Matic
    In order to build your wealth you have to invest. Investing is the ability which allows you to put your money in vehicle that have the potential to earn strong rate of return.
  • S
    Sean
    The current EU supply agreement is worth around 1 billion euro to Valneva...would that be correct? While their total market cap is only 1.5B euro. Looks like another covid wave could be incoming...if the EU approves this in April just as another wave hits then that could be extra bullish for price. Whatever about the long term success of this (and you could make a moderately bullish argument for that now that the jab has been validated by the UK health health authority) it could be worth throwing down at this price as a purely short term speculative play. I'm in (again), let's go!
  • D
    Dennis
    VALN, is the best and safest Vaccine. No spike proteins and other graphic metal bio blades trash and nanobots etc. like MRNA and PFE Vaccines don't work and harm people.
  • D
    Dennis
    Marcello reply to bos own devious posts. look it up. this #$%$ has decent #s, potential, lots of cash and the drop in price from manipulation is staggering. when most bought this stock it had all ten anylist saying "Strong Buy"??. promoted by Robinhood to fleece young investors. I know this as I opened an account back then just to see how it works.This shorting should be investigated. Big Pharma Shorters?Any one interested?
  • M
    Marcelino
    I told you Strong sell ! last month, check it out
  • J
    John
    think this will slowly creep back up. Europe has big deal with valneva. just dragging their feet a bit over approval. I Neen 15 to break even. would sell if it gets back to 19
  • S
    StratDD
    As announced on February 25, 2022, Valneva received a list of questions as part of the CHMP’s initial assessment to which it responded within two working days. Valneva has now received a small set of additional questions and is confident it will be able to respond to these in the coming days.

    With this additional round of questions and a tentative timetable also received from the EMA, and subject to the CHMP’s acceptance of Valneva’s responses, Valneva now anticipates receiving a positive CHMP recommendation for conditional approval of VLA2001 for primary immunization in adults 18 to 55 years of age in April 2022. Following such conditional approval, the Company would expect to start delivering planned doses of VLA2001 to European countries in the second quarter of 2022.

    https://finance.yahoo.com/news/valneva-provides-regulatory-covid-19-060000284.html
    Saint Herblain (France), March 11, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today provided an update on the regulatory review of its inactivated, COVID-19 vaccine candidate, VLA2001, by the Committee for Med
    Saint Herblain (France), March 11, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today provided an update on the regulatory review of its inactivated, COVID-19 vaccine candidate, VLA2001, by the Committee for Med
    finance.yahoo.com
  • B
    Bob
    Why the big rise in pre?
  • S
    StratDD
    expects a positive recommendation from the EMA for its VLA2001 COVID-19 candidate vaccine in April.

    Valneva Secures £20M From Scottish Enterprise For Vaccine Development.
    “Following such conditional approval, the company would expect to start delivering planned doses of VLA2001 to European countries in the second quarter of 2022,” said Valneva.

    Valneva signed an agreement with the European Commission (EC) in November 2021 to supply up to 60 million doses of VLA2001 over two years, including 24.3 million doses in 20221 and an option for delivery of the remaining doses in 2023.

    Valneva also signed an agreement with the Kingdom of Bahrain in December 2021 to supply 1 million doses of VLA20012.

    The Company has commenced manufacturing for the EC and Bahraini supply contracts

    https://www.billionaireclubcollc.com/valn-european-recommendation-on-valnevas-covid-19-shot-pushed-into-april/
  • L
    LostMyShirt
    THIS is why it is not at all too late for new entrants such as VALNEVA . The Pandemic is far from over and Shanghai is one example of what could happen anywhere. This article is very good;

    https://www.theguardian.com/commentisfree/2022/apr/12/herd-immunity-covid-reinfection-virus-world
  • p
    peter
    The big question is will VALN's vaccine have more durability when it comes to severe disease with its broader antigen coverage.